LONG-TERM DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION

被引：0

作者：

Bone, H. ^{[1
]}

Chapurlat, R. ^{[2
]}

Brandi, M. ^{[3
]}

Brown, J. ^{[6
]}

Czerwinski, E. ^{[4
]}

Daizadeh, N. ^{[5
]}

Grauer, A. ^{[5
]}

Krieg, M. ^{[6
]}

Man, Z. ^{[7
]}

Mellstrom, D. ^{[8
]}

Radominski, S. ^{[9
]}

Reginster, J. ^{[10
]}

Resch, H. ^{[11
]}

Roman, J. ^{[12
]}

Roux, C. ^{[13
]}

Cummings, S. ^{[14
]}

Libanati, C. ^{[8
]}

Papapoulos, S. ^{[15
]}

Thiebaud, D. ^{[16
]}

机构：

[1] Michigan Bone & Mineral Clin, Detroit, MI 91320 USA

[2] Hop Edouard Herriot, Lyon, France

[3] Univ Florence, Florence, Italy

[4] Krakow Med Ctr, BR-80060000 Krakow, Poland

[5] Amgen Inc, Thousand Oaks, CA USA

[6] Univ Lausanne Hosp, Lausanne, Switzerland

[7] Ctr TIEMPO, Buenos Aires, DF, Argentina

[8] Sahlgrens Univ Hosp, Gothenburg, Sweden

[9] Univ Fed Parana, Curitiba, Parana, Brazil

[10] Univ Liege, Liege, Belgium

[11] St Vincents Hosp, Vienna, Austria

[12] Hosp Univ La Fe, Valencia, Spain

[13] Paris Descartes Univ, Paris, France

[14] San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA USA

[15] Leiden Univ, Med Ctr, Leiden, Netherlands

[16] Amgen Australia Pty Ltd, Sydney, NSW, Australia

来源：

OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S527 / S528

页数：2

共 50 条

[41] Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension
Hans, Didier
McDermott, Michele
Huang, Shuang
Kim, Min
Shevroja, Enisa
McClung, Michael
OSTEOPOROSIS INTERNATIONAL, 2023, 34 (06) : 1075 - 1084
[42] TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH CALCITONIN AND CALCIUM - LONG-TERM RESULTS
LENZA, HR
DIEZ, ERH
NUNEZTORRON, M
ARANGUREN, JT
PEREZ, DE
MEDICINA CLINICA, 1985, 84 (14): : 563 - 565
[43] The DATA Extension Study: 2 Years of Combined Denosumab and Teriparatide in Postmenopausal Women with Osteoporosis: A Randomized Controlled Trial
Leder, Benjamin
Uihlein, Alexander
Tsai, Joy
Neer, Robert
Siwila-Sackman, Erica
Zhu, Yuli
Foley, Katelyn
Lee, Hang
Burnett-Bowie, Sherri-Ann
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
[44] Long-Term Treatment of Postmenopausal Osteoporosis
Brown, Jacques P.
ENDOCRINOLOGY AND METABOLISM, 2021, 36 (03) : 544 - 552
[45] LONG-TERM EFFECT OF DENOSUMAB ON BONE MICROARCHITECTURE AS ASSESSED BY TISSUE THICKNESS-ADJUSTED TRABECULAR BONE SCORE (TBS) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM AND OPEN-LABEL EXTENSION (OLE)
Hans, D.
Mcdermott, M.
Huang, S.
Kim, M.
Shevroja, E.
Mcclung, M.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S157 - S158
[46] Letter to the Editor: "Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis"
Sugiyama, Toshihiro
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07): : 2756 - 2757
[47] LONG-TERM TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN WITH STRONTIUM RANELATE: RESULTS AT 10 YEARS
Reginster, J. Y.
Kaufman, J. -M.
Goemaere, S.
Benhamou, C. L.
Balogh, A.
Albanese, C.
Badurski, J.
Roux, C.
OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S665 - S666
[48] Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term clinical trial
Filipponi, P
Cristallini, S
Rizzello, E
Policani, G
Fedeli, L
Gregorio, F
Boldrini, S
Troiani, S
Massoni, C
BONE, 1996, 18 (02) : 179 - 184
[49] Long-term treatment strategies for postmenopausal osteoporosis
Cosman, Felicia
CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (04) : 420 - 426
[50] LONG-TERM TREATMENT WITH CALCITRIOL IN POSTMENOPAUSAL OSTEOPOROSIS
CANIGGIA, A
NUTI, R
LORE, F
MARTINI, G
TURCHETTI, V
RIGHI, G
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (04): : 43 - 49

← 1 2 3 4 5 →